CIK 0000943819 · Large accelerated filer
RESMED INC
Sign in to watch- Tickers
- RMD RSMDF
- Exchange
- NYSE, OTC
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Jun 30
- Incorporated
- DE
- Entity type
- operating
- EIN
- 980152841
- Phone
- 8587462400
- Business address
- 9001 SPECTRUM CENTER BLVD., SAN DIEGO, CA, 92123
Securities
- RMD ResMed Inc. Common Stock NYSE
- RSMDF Common stock OTC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $3,744,605
- in 5 filings, $3.7M under 10b5-1 plans
Net −$3,744,605. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-07-22 | Sandercock Brett Chief Financial Officer | Option exercise | +2,500 | $57.76 | $144K | 111,426 |
| 2022-07-22 | Sandercock Brett Chief Financial Officer | Option exercise | +2,500 | $57.76 | $144K | 113,926 |
| 2022-07-22 | Sandercock Brett Chief Financial Officer | Sale | −7,500 | $235.00 | $1.8M | 106,426 |
| 2022-07-22 | Sandercock Brett Chief Financial Officer | Option exercise · ResMed Common Stock Options | −2,500 | 7,500 | ||
| 2022-07-22 | Sandercock Brett Chief Financial Officer | Option exercise · ResMed Common Stock Options | −2,500 | 5,000 | ||
| 2022-07-22 | Sandercock Brett Chief Financial Officer | Option exercise · ResMed Common Stock Options | −2,500 | 2,500 | ||
| 2022-07-15 | Farrell Michael J. Chief Executive Officer | Option exercise | +5,675 | $57.76 | $328K | 410,935 |
| 2022-07-15 | Farrell Michael J. Chief Executive Officer | Sale | −5,675 | $224.94 | $1.3M | 405,260 |
| 2022-07-15 | Farrell Michael J. Chief Executive Officer | Option exercise · ResMed Common Stock Options | −5,675 | 94,265 | ||
| 2022-07-05 | PENDARVIS DAVID Chief Administrative Officer | Sale | −1,545 | $212.33 | $328K | 106,831 |
| 2022-06-15 | Farrell Michael J. Chief Executive Officer | Option exercise | +5,675 | $57.76 | $328K | 410,935 |
| 2022-06-15 | Farrell Michael J. Chief Executive Officer | Sale | −5,675 | $202.54 | $1.1M | 405,260 |
| 2022-06-15 | Farrell Michael J. Chief Executive Officer | Option exercise · ResMed Common Stock Options | −5,675 | 99,940 | ||
| 2022-06-03 | PENDARVIS DAVID Chief Administrative Officer | Sale | −1,545 | $209.44 | $324K | 108,376 |
| 2022-05-16 | Farrell Michael J. Chief Executive Officer | Option exercise | +5,675 | $57.76 | $328K | 410,935 |
| 2022-05-16 | Farrell Michael J. Chief Executive Officer | Sale | −5,675 | $196.61 | $1.1M | 405,260 |
| 2022-05-16 | Farrell Michael J. Chief Executive Officer | Option exercise · ResMed Common Stock Options | −5,675 | 105,615 | ||
| 2022-05-03 | PENDARVIS DAVID Chief Administrative Officer | Sale | −1,545 | $200.00 | $309K | 109,858 |
| 2022-04-18 | Farrell Michael J. Chief Executive Officer | Option exercise | +5,675 | $57.76 | $328K | 410,904 |
| 2022-04-18 | Farrell Michael J. Chief Executive Officer | Sale | −5,675 | $232.41 | $1.3M | 405,229 |
Page 27 of 28 · 548 trades